Authors
Pronin A.G., Troshina A.A.
Pirogov National Medical and Surgical Center, Moscow
Abstract
Predicting and preventing the development of death and chronic thromboembolic hypertension in patients with pulmonary embolism is one of the urgent problems of modern medicine. The introduction into clinical practice of stratification of the risk of early death from pulmonary embolism has made it possible to optimize the treatment of these patients in many ways. However, uncertainty remains in the choice of the volume of therapy in patients with moderate risk of early death. What underlies the often incorrect choice of treatment tactics and, as a result, the development of chronic thromboembolic pulmonary hypertension in these patients, more often than in other patients. Many researchers see ways to solve this problem in establishing new echocardiographic criteria for the severity of pulmonary embolism. This article analyzes modern literary data and the results of their own research. The superiority of determining the pressure gradient on the pulmonary artery valve, calculated on the basis of measuring the volume of the heart ejected into the aorta in one systole during echocardiography, over most widely used parameters is shown.
Keywords: pulmonary embolism, prognosis of disease outcomes, echocardiography, chronic thromboembolic pulmonary hypertension.
References
1. Berns SA, Shmidt EA, Neeshpapa AG, et al. Risk factors associated with the development of death events during the first year of follow-up after pulmonary thromboembolism. Medical Council. 2019; 5: 80-85 (In Russ.) doi: 10.21518/2079–701X–2019–5–80–85.
2. Mullova IS, Chaulin AM, Svechkov AI, et al. Experimental models of pulmonary embolism. Russian Journal of Cardiology. 2022; 27(1S): 4887. (In Russ.) doi: 10.15829/1560-4071-2022-4887.
3. Dimitrieva OV, Busalaeva EI, Vasilieva NP, et. al. Pulmonary thrombolism in real clinical practice. Transbaikalian medical bulletin. 2020: 4; 17-26. (In Russ.)
4. Johansson M. Epidemiology of venous thromboembolism with focus on risk markers : doctoral thesis, comprehensive summary. Umea University, 2019. Р.215.
5. Becattini C, Agnelli G. Acute treatment of venous thromboembolism. Blood. 2020; 5: 305-316. doi: 10.1182/blood.2019001881.
6. Konstantinides SV, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). European Heart Journal. 2020; 41: 543-603. doi: 10.1093/eurheartj/ehz405.
7. Jiménez D, Bikdeli B, Barrios D, et al. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. International Journal of Cardiology. 2018; 269: 327-33. doi: 101016/j.ijcard.2018.07.059.
8. Nikulina NN, Terekhovskaya YuV. Epidemiology of pulmonary embolism in today’s context: analysis of incidence, mortality and problems of their study. Russian Journal of Cardiology. 2019; 24(6): 103-108. (In Russ.) doi: 10.15829/1560–4071–2019–6–103–108.
9. Makarova NV, Busalaeva EI, Tuyzarova IA, Vize-Khripunova MA. Pulmonary embolism: Challenges in clinical diagnosis. Ulyanovsk Medico-biological Journal. 2022; 3: 35-42. (In Russ.) doi: 10.34014/2227-1848-2022-3-35-42.
10. Kokov LS. Pulmonary embolism. Classical diagnostics, the latest methods of prevention and treatment: a guide for doctors. Moscow: RAS; 2022. 378 p. (In Russ.)
11. Ovchinnikov YV, Zelenov MV, Polovinka VS, Kryukov EV. Present aspects of thrombolytic therapy of pulmonary artery thromboembolism. Clinical Medicine. 2021; 99(1): 6-14. (In Russ.) doi: 10.30629/0023-2149-2021-99-1-6-14.
12. Nikulina NN, Terekhovskaya YuV, Yakushin SS. Antithrombotic Therapy and the Nearest Forecast of Pulmonary Embolism in Rutine Clinical Practice (Data of the Regional Vascular Center of the Ryazan Region). Rational Pharmacotherapy in Cardiology 2022; 18(2): 135-142. (In Russ.) doi: 10.20996/1819-6446-2022-04-13.
13. Fyodorov SA, Medvedev AP, Tselousova LM, et al. Immediate results of surgical treatment of high and intermediate risk pulmonary embolism in elderly and senile patients. Clinical Medicine. 2021; 99(7-8): 451-456. (In Russ.) doi: 10.30629/0023-2149-2021-99-7-8-451-456.
14. Vasiltseva OYa, Edemskiy AG, Grankin DS, et al. From pulmonary embolism to chronic thromboembolic pulmonary hypertension: risk factors. Patologiya krovoobrashcheniya i kardiokhirurgiya. Circulation Pathology and Cardiac Surgery. 2021; 25(3): 11-19. (In Russ.) doi: 10.21688/1681-3472-2021-3-11-19.
15. Klok F, Delcroix M, Bogaard H. Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism. Journal of Thrombosis and Haemostasis. 2018; 16: 1040-1051. doi: 10.1111/jth.14016.
16. Chaulin AM, Karslyan LS, Duplyakov DV. Non-Coronarogenic Causes of Increased Cardiac Troponins in Clinical Practice. Journal of Clinical Practice. 2019; 10(4): 81-93. (In Russ.) doi: 10.17816/clinpract16309.
17. Zatevakhin II, Kiriyenko AI, Stoiko YuM, et al. Diagnostics and Treatment of Chronic Venous Disease: Guidelines of Russian Phlebological Association. Flebologiya. 2018; 12(3): 146-240. (In Russ.) doi: 10.17116/flebo20187031146.
18. Kochmareva ЕА , Kokorin VА, Volkova АL, et al. Predictors of short term outcomes in high and moderate risk pulmonary thromboembolism. Russian Journal of Cardiology. 2017; 9: 7-12. (In Russ.) doi: 10.15829/1560–4071–2017–9–7–12.
19. Delmas C, Aissaoui N, Meneveau N, et al. Reperfusion therapies in pulmonary embolism-state of the art and expert opinion: A position paper from the “Unite de Soins Intensifs de Cardiologie” group of the French Society of Cardiology. Arch Cardiovasc Dis. 2020; 11: 749-759. doi: 10.1016/j.acvd.2020.06.002.
20. Podlipaeva AA, Mullova IS, Pavlova TV, et al. Novel biological markers for the diagnosis and prediction of mortality risk in patients with pulmonary embolism. Russian Journal of Cardiology. 2020; 25(4S): 4202. (In Russ.) doi: 10.15829/1560–4071–2020–4202.
21. Barco S, Mahmudpur SH, Plunketka B, et al. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis. European Heart Journal. 2019; 11: 902-910. doi: 10.1093/eurheartj/ehy873.
22. Netylko J, Teterina M, Pisaryuk A, et al. Prognostic value of echocardiographic parameters in patients with pulmonary embolism. Klinicheskaya farmakologiya i terapiya. 2021; 30(3): 52-56 (In Russ.) doi: 10.32756/0869-5490-2021-3-52-56.
23. Panchenko EP, Balahonova TV, Danilov NM, et al. Diagnosis and Management of pulmonary embolism: Eurasian Association of Cardiology (EAC) Clinical Practice Guidelines (2021). Eurasian heart journal. 2021; 1: 44-77. (In Russ.) doi: 10.38109/2225-1685-2021-1-44-77.
24. Dzhioeva ON, Orlov DO, Nikitin IG. Echocardiography in acute cardiovascular care. Part 2. Cardiac and lung ultrasound examination. Complex Issues of Cardiovascular Diseases. 2020; 9(3): 49-58. (In Russ.) doi: 10.17802/2306–1278–2020–9–3–49–58.
25. Avdeev SN, Barbarash OL, Bautin AE, et al. 2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology. 2021; 26(12): 4683. (In Russ.) doi: 10.15829/ 1560-40712021-4683.
26. Burgos LM, Scatularo CE, Cigalini IM, et al. The addition of echocardiographic parameters to PESI risk score improves mortality prediction in patients with acute pulmonary embolism: PESI-Echo score // European Heart Journal Acute Cardiovascular Care. 2021; 10(3): 250-257. doi: 10.1093/ehjacc/zuaa007.
27. Lahham S, Fox JC, Thompson M, et al. Tricuspid annular plane of systolic excursion to prognosticate acute pulmonary symptomatic embolism (TAPSEPAPSE study). Journal of Ultrasound in Medicine. 2019; 38(3): 695-702. doi: 10.5811/westjem.2019.11.44968.
28. Lyhne MD, Kabrhel C, Giordano N, et al. The echocardiographic ratio tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure predicts short-term adverse outcomes in acute pulmonary embolism. Eur Heart J Cardiovasc Imaging. 2021; 22(3): 285-294. doi: 10.1093/ehjci/jeaa243.
29. Erlikh AD, Barbarash OL, Berns SA, et al. SIRENA score for in-hospital mortality risk assessment in patients with acute pulmonary embolism. Russian Journal of Cardiology. 2020; 25(4S): 4231 (In Russ.) doi: 10.15829/1560-4071-2020-4231.
30. Bautin AE, Osovskikh VV. Acute right ventricular failure. Messenger of Anesthesiology and Resuscitation. 2018; 15(5): 74-86. (In Russ.) doi: 10.21292/2078-5658-2018-15-5-74-86.
31. Bartholomew JR. Pulmonary Embolism in the Intensive Care Unit: Therapy in Subpopulations. Crit Care Clin. 2020; 36(3): 547-60. doi: 1011016/j.ccc.2020.03.001.
32. Kaplovitch E, Shaw JR, Douketis J. Thrombolysis in Pulmonary Embolism: An Evidence-Based Approach to Treating Life-Threatening Pulmonary Emboli. Crit Care Clin. 2020; 36(3): 465-80. doi: 101016/j.ccc.2020.02.004.
33. Pronin AG, Sivokhina NYu, Goncharov MA. Overload of the right ventricle in patients with pulmonary embolism: analysis of new evaluation criteria. I.P. Pavlov Russian Medical Biological Herald. 2023; 31(3): 415-426. (In Russ.) doi: 10.17816/PAVLOVJ119868.
34. Pronin AG, Sivokhina NYu, Corrected pressure gradient index on the pulmonary artery valve in patients with pulmonary embolism. MIA Medical Bulletin. 2023; 123(2): 27-31. (In Russ.)]. doi: 10.52341/20738080_2023_123_2_27.
35. Sivukhin DV. General course of physics. V.I. Mechanics. Textbook for universities. Moscow: Fizmatlit, 2020. 560 p. (In Russ.)
36. Yevlakhov VI, Pugovkin AP, Rudakova TL, Shalkovskaya LN. Introduction to the physiology of the heart. SPb: SpetsLit, 2019. 311 p. (In Russ.)
37. Kul’chiev AA, Morozov AA, Kul’chieva LM. Visualization diagnostics of pulmonary thromboembolism. Сhief physician of the South of Russia. 2021; 76(1): 9-14 (In Russ.)
38. Shlyakhto EV. Cardiology. National leadership. Short edition. Moscow: GEOTAR-Media. 2019: 816. (In Russ.)
